Area at risk (AAR) is an important parameter for the assessment of the salvage area after revascularization in acute myocardial infarction (AMI). By combining AAR assessment by T2-weighted imaging and scar quantification by late gadolinium enhancement imaging cardiovascular magnetic resonance (CMR) offers a promising alternative to the ''classical'' modality of Tc99m-sestamibi single photon emission tomography (SPECT). Current T2 weighted sequences for edema imaging in CMR are limited by low contrast to noise ratios and motion artifacts. During the last years novel CMR imaging techniques for quantification of acute myocardial injury, particularly the T1-mapping and T2-mapping, have attracted rising attention. But no direct comparison between the different sequences in the setting of AMI or a validation against SPECT has been reported so far. We analyzed 14 patients undergoing primary coronary revascularization in AMI in whom both a pre-intervention Tc99m-sestamibi-SPECT and CMR imaging at a median of 3.4 (interquartile range 3.3-3.6) days after the acute event were performed. Size of AAR was measured by three different non-contrast CMR techniques on corresponding short axis slices: T2-weighted, fat-suppressed turbospin echo sequence (TSE), T2mapping from T2-prepared balanced steady state free precession sequences (T2-MAP) and T1-mapping from modified look locker inversion recovery (MOLLI) sequences. For each CMR sequence, the AAR was quantified by appropriate methods (absolute values for mapping sequences, comparison with remote myocardium for other sequences) and correlated with Tc99m-sestamibi-SPECT. All measurements were performed on a 1.5 Tesla scanner. The size of the AAR assessed by CMR was 28.7 ± 20.9 % of left ventricular myocardial volume (%LV) for TSE, 45.8 ± 16.6 %LV for T2-MAP, and 40.1 ± 14.4 %LV for MOLLI. AAR assessed by SPECT measured 41.6 ± 20.7 %LV. Correlation analysis revealed best correlation with SPECT for T2-MAP at a T2-threshold of 60 ms (ms) (slope = 0.99, Pearson's r = 0.94), and for MOLLI at T1-threshold of 1,075 ms (slope 0.86, r = 0.91, Pearson's r = 0.45). For the assessment of AAR in AMI, the novel T2-mapping technique correlates best with SPECT size, T1-mapping with MOLLI and standard T2-weighted imaging showed similar good correlations.
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Background
Primary angioplasty for coronary revascularization is a highly effective treatment in acute myocardial infarction (AMI) as it re-establishes myocardial perfusion and prevents further ischemic myocardial injury. For assessment of the Birgit Langhans and Jonathan Nadjiri contributed equally to this work.
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Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany beneficial effect of therapy in AMI, both by medication and by primary percutaneous coronary intervention (PCI), evaluation of the myocardium regarding area at risk (AAR), scar tissue and salvaged tissue is a useful tool in patients surveillance and furthermore an established surrogate parameter in clinical studies. The AAR is defined as hypoperfused myocardial tissue during an ischemic episode [1] [2] [3] . The established modality to assess the AAR is single photon emission computed tomography (SPECT) using Tc99m sestamibi. The radiotracer is injected prior to PCI and accumulates in perfused myocardium only. Since the circulating radiotracer is eliminated within minutes, image acquisition can be done after intervention. Radiotracer injection prior to PCI makes the technically simple and fast examination logistically challenging. In addition, it is limited by low spatial resolution [4] and radiation exposure to both the patient and the staff performing the PCI.
In recent years cardiac magnetic resonance (CMR) using T2 weighted imaging emerged as an alternative modality for AAR assessment. T2 signal in CMR is elevated in tissue with increased water content, which in case of acute infarction is caused by the metabolic impairment in ischemic myocardium resulting in cell swelling and inflammation. Elevated T2 signals are a reproducible finding in AMI, the size of T2 changes is equal to or larger than the size of late enhancement depicting the myocardial scar, and the AAR assessed by CMR correlates well with SPECT and outcome [5] [6] [7] . AAR assessment by CMR has advantages over SPECT; it does not expose the patient to ionizing radiation and can be performed together with scar quantification several days after reperfusion.
On the other hand T2-weighted imaging using dark blood turbospin echo sequences (TSE) has several limitations. Contrast to noise ratio (CNR) is quite low; therefore a threshold of 2 SD deviations above healthy myocardium has to be used for automated quantification. In addition, it is prone to motion artefacts and signal drop outs, particular in patients with tachycardia.
Recently, non-contrast T1-and T2-mapping sequences emerged as a promising alternative overcoming some of these limitations [8, 9] . Mapping sequences allow for a per voxel calculation of the absolute relaxation time eliminating the need of comparison with assumed healthy tissue. They are based on balanced steady state free precession single shot sequences, which may reduce motion artifacts. It could be demonstrated that the AAR in AMI is consistently associated with elevated relaxation times in non-contrast T1 [10, 11] and T2 [12, 13] -imaging. Previous studies have also shown a good correlation between native T1-and T2 mapping in edema [12, 14] and a superior performance of T1-mapping compared to T2w-darkblood imaging [10] .
Up to now it remains unclear whether the novel mapping sequences can be used for quantification of AAR in the same way as T2-tse sequences or SPECT and particularly which thresholds have to be used in this approach. Therefore, the purpose of this study was to evaluate the correlation of the AAR size in AMI measured by three different non-contrast CMR techniques on corresponding short axis slices: T2-weighted, fat-suppressed dark blood TSE, T2-mapping from T2-prepared balanced steady state free precession sequences (T2-MAP) and T1-mapping (MOLLI) and compare them to the reference standard SPECT.
Methods

Study population and design
This study includes all patients undergoing both CMR and Tc99m sestamibi SPECT for AAR assessment after acute PCI in AMI between April and August 2012. None of the patients had contraindications for CMR and SPECT (pacemaker, implantable cardioverter defibrillator, other incompatible medical implants, intracorporal foreign bodies, claustrophobia, patients that are hemodynamically unstable at presentation or during the following 5 days). Patients were diagnosed with AMI if they presented with typical chest pain lasting at least 20 min and with ST-segment elevation in at least two limb leads of 0.1 millivolt (mV) or at least 0.2 mV in more than 2 precordial leads. Patients with prior myocardial infarction were excluded to ensure that CMR findings displayed acute myocardial injury. All patients gave written informed consent for both investigations. The study protocol was approved by the institutional ethics committee.
Myocardial perfusion SPECT
The methods used for the radionuclide studies have been previously described in detail [15] . Image acquisition was performed with the patient in supine position. A dual-head camera system with low-energy, high resolution collimators was used for the radionuclide studies. Images were acquired ECG-gated in a 64-by-64 matrix with an acquisition time of 40 s (s) per image. A volumetric sampling tool was applied to create polar maps of the relative distribution of activity throughout the left ventricle (LV). Each polar map was adjusted for its own maximal value. The size of the defect was calculated with the use of a threshold of 50 %, according to previously described methods [16, 17] . AAR was expressed as a proportion of the LV.
Cardiac magnetic resonance
CMR was performed on a 1.5-T system (Siemens Avanto, Siemens Medical Solutions, Erlangen, Germany) equipped with a dedicated cardiac phased-array surface coil. For image acquisition, patients were positioned in supine position, and images were acquired at repeated end-expiratory breath holds with ECG triggering. Size of AAR was measured by three different non-contrast CMR techniques on corresponding contiguous short axis slices of the LV with 8-millimeter (mm) slice thickness.
A dark blood T2 weighted TSE sequence [field of view (FOV) 340 9 276 mm, matrix 128 9 192, echo time (TE) 99 ms (ms), repetition time (TR) 2 RR intervals up to a heart rate of 100 beats per second or 3 RR-intervals at a higher heart rate], T1 mapping using a modified look-locker inversion recovery (MOLLI) sequence with three inversion pulses and a 3-(3)-3-(3)-5 readout pattern (MOLLI-start 100 ms, MOLLI-increment 80 ms. Matrix 192 9 192, FOV 340 9 272 mm, TE 1.06 ms, TR 2.4 ms), and T2 mapping using 3 balanced steady state free precession single shot images with different T2-preparation pulses (0, 24, 55 ms as proposed by Giri and coworkers [8] ) at an interval of 4 RR pulses (FOV 340 9 276 mm, matrix 192 9 192 mm, TE 1.1 ms, TR 2.6 ms). For image examples see Fig. 1 .
For defect quantification, endocardial and epicardial contours were manually traced on each of the short-axis slices by an experienced reader. For T2-TSE the defect size was calculated automatically by comparison with manually marked, healthy remote myocardium using a multiple of the standard deviation of signal intensity in the remote myocardium and omitting small areas \10 pixel in size [6, 7] . Since upper limit of normal values for the novel mapping sequences is strongly dependent on the scanning set-up and it is recommended to establish site specific reference values [18] , different thresholds were tested for optimization. The size of the AAR was expressed as the percentage of total LV myocardial volume.
Signal to noise ratio (SNR) was defined as mean signal intensity divided by the standard deviation of signal intensity in healthy myocardium, Contrast to noise ratio (CNR) was defined as the difference between mean signal intensity in diseased myocardium and healthy myocardium divided by the standard deviation of signal intensity in healthy myocardium.
Statistical analysis
Categorical variables were expressed as frequencies and percentages, continuous variables were expressed as mean ± SD or, for the more skewed clinical parameters and time intervals, as median and interquartile range (IQR). Comparison between continuous variables was done using the Student t test; for categorical variables, the Fisher exact test was used. Correlation between T1 map, T2 map, T2w and SPECT was calculated using a linear regression model. Correlation coefficients were compared using Fisher's Z-transform [19] . Statistical significance was accepted for 2-sided p values of 0.05. The statistical package R version 2.10.1 [20] was used for statistical analysis.
Results
Study population and clinical characteristics
During the study period 14 patients with AMI treated by primary PCI underwent SPECT and CMR. The age of the patients was 63.3 ± 13.6 years, and 9 patients (64 %) were male. The majority of the patients (10 or 71 %) presented in stable condition in Killip class 1. A detailed summary of the patients' characteristics is provided in Table 1 . From the patients included, 2 (14 %) had an inferior, 2 (14 %) had a lateral wall and 10 (71 %) had an anterior wall myocardial infarction. Door to balloon time was 8.5 h (IQR 3.9-11.9). Prior to PCI, 8 patients (57 %) had a total coronary occlusion (TIMI 0), while 6 patients (43 %) had a residual perfusion of the infarcted area (TIMI C 1). For further details of the infarct characteristics, please refer to Fig. 2 .
Discussion
The novel T1-and T2-mapping sequences correlate just as well with the external reference standard of SPECT as conventional dark blood T2-TSE. Best correlation with SPECT was found using a threshold for diseased myocardium of 60 ms in T2-mapping and 1,075 ms in T1-mapping. At these thresholds correlation with SPECT was nominally, but not significantly better than for T2-TSE.
The tendency of T2-TSE to underestimate the AAR particularly in larger infarcts that was observed both in this study and a previous analysis [15] was not observed in the mapping sequences. While T2-TSE underestimated the AAR by 30 % on average and even more in larger infarcts, T2-mapping showed a nearly identical mean defect size in comparison to SPECT with a slope of the regression line of nearly 1. In concordance with this observation, Verheart et al. [9] reported less frequent detection of edema in myocardial infarction by T2 STIR imaging compared to T2 mapping, particularly in NSTEMI patients. Additionally Park et al. demonstrated better detection of increased T2 values using T2 mapping rather than T2w-imaging [21]. T1-mapping had only a slight tendency to underestimate AAR, a phenomenon that has been described before in accordance to our findings [12] .
While an experimental study showed a linear relationship with a good correlation between T2 value and percentage of water content [22] , in vivo processes are more complex. First, the edema of ischemic myocardium can cause wall thickening, which is assessed by the threedimensional CMR analysis but not by the SPECT algorithm using a two-dimensional surface model. Second, CMR is performed during the healing phase of the myocardial infarction and the size of elevated T2-signal can vary depending on infarct size and time between injury and scan. While all these factors influence T2-TSE as well as the mapping sequences, the better correlation of the latter with SPECT is indicative that the quantitative assessment of the mapping sequences more precisely detects the ischemic changes in AMI than conventional T2-TSE.
T2-TSE has a quite low CNR and a threshold of 2 SD above signal intensity of remote myocardium is commonly used for identification of diseased myocardium. Without PCI percutaneous coronary intervention TIMI thrombolysis in myocardial infarction correction by omitting small areas this would lead to a false positive classification of about 2 % of healthy myocardium. Unfortunately, CNR of the mapping sequences was even lower than in T2-TSE. At the optimal threshold of 60 ms, T2-map has a CNR of 1.8 and the threshold found is just at the published upper limit of normal [9, 21] . T1-map has a similar CNR of 1.9 at a threshold of 1,075 ms, but this threshold has quite a margin to the commonly used upper limit of normal of 990 ms [23] . T1-map may therefore be more robust against artifacts. The question which of the both mapping sequences should be preferred for AAR assessment cannot be clearly answered by the results of this study. T2-map has a slightly better correlation with SPECT without relevant underestimation, while T1-map has a slightly better CNR and a wider margin to the upper limit of normal. Regarding image acquisition, T1-map using the standard MOLLI readout pattern requires 17 heart beats for acquisition, which may increase motion artifact particularly in older patients. This limitation may be overcome by faster modified readout pattern like ShMOLLI [24] . T2-map requires only 9 RR-intervals, but the calculation of T2 from just 3 measurements may be vulnerable to artifacts, too.
Besides the small study population this analysis has some methodical limitations. SPECT and CMR measure different pathophysiological phenomena in the ischemic response of myocytes. While the accumulation of sestamibi in the myocytes is mainly affected by the myocardial blood flow at the time shortly after injection [25] , T2-imaging in CMR relies on the metabolic response to ischemia, mainly electrolyte imbalances through low Na ? K ? -ATPase activity and endothelial leakage leading to reversible cell swelling [26] [27] [28] , and findings in T1-mapping are most likely due to the same pathophysiological alterations [10, 14] . This may lead to different results, for example in the case of subtotal occlusion or spontaneous revascularization. Having said Fig. 2 Results for the three sequences analysed: T2turbospin on the left, T2-map in the middle, T1-map on the right. Top line depicts the correlation with SPECT at the optimal thresholds, second line depicts correlation coefficient, correlation slope and difference in percentage of left ventricular volume for different thresholds, bottom line shows signal to noise ratio (SNR) and contrast to noise ratio (CNR) for different thresholds. Area at risk denotes AAR that, SPECT is the only alternative available as external basis of a comparison in the clinical setting.
Conclusion
Native T1-and T2-mapping sequences are equally suitable for assessing the AAR in AMI compared to conventional dark blood T2-TSE. In contrast to T2-TSE they do not underestimate the AAR when compared to SPECT as external reference, however signal to noise ratio is not better than conventional T2-TSE.
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